TYP
Click for more information
10.5% 2.1¢ tryptamine therapeutics limited

Ann: Quarterly Activities Report and Appendix 4C, page-23

  1. shakespeare
    2,124 Posts.
    lightbulb Created with Sketch. 45
    clock Created with Sketch.
    28/10/21
    14:33
    Post #: 57147975
    In my opinion EX1s philosophy is much like their (somewhat related by personel) stem cell company CYP.
    they believe they have a novel process for large scale production.
    Relying on their process being picked up by some majors in this space.
    Trials and patents on the use of them is far too risky and much too hard work.
    Decide for yourself!
    EX1 Price at posting: 49.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
SUN ANZ deal to buy Suncorp to go ahead following approval from Treasurer
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
2.1¢ 		Change
0.002(10.5%) 		Mkt cap ! $22.87M
Open High Low Value Volume
1.9¢ 2.1¢ 1.9¢ $27.87K 1.464M

Buyers (Bids)

No. Vol. Price($)
2 527780 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 613000 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.